Features June 2007 Issue

A New Weapon Against Hypertension

Recently approved medication lowers blood pressure, reducing risks of heart failure, stroke, heart attack, aneurysm, and kidney failure.

It’s been more than a decade since doctors received a new drug to help them battle hypertension (high blood pressure) in patients. During that time, the hypertension epidemic has grown to affect an estimated 25 percent of Americans—and it still remains uncontrolled in nearly 70 percent of those who have it. That’s why the recent approval of a new hypertension drug—aliskiren (Tekturna)—by the U.S. Food and Drug Administration (FDA) is of interest.

To continue reading this article you must be a paid subscriber.

Subscribe to Heart Advisor

Get the next year of HEART ADVISOR for just $20. That's a savings of $19 off the regular rate.

With your paid subscription you will receive unlimited access to all of our online content. That is over a decade of previous issues from Cleveland Clinic, the hospital rated #1 in cardiac care by U.S. News & World Report - free of charge.

Subscriber Log In

Forgot your password? Click Here.

Already subscribe but haven't registered for all the benefits of the website? Click here.